The Joint Corp.

Healthcare

NASDAQ:JYNT · NASDAQ Capital Market

Market Cap $131.60M Beta 1.10 P/E (TTM) 41.9

$9.24 +5.27%

+$0.48 today

52W Low $7.50High $13.00

Vol 0.04M · Avg 0.07M

EPS (TTM) $0.23Medical - Care Facilities

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-16.15%

Period High

$11.99

Period Low

$7.67

Latest

$9.24

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Inhibikase Therapeutics, Inc.

NASDAQ:IKT

$220.49M

Apyx Medical Corporation

NASDAQ:APYX

$196.39M

biote Corp.

NASDAQ:BTMD

$108.50M

Lucid Diagnostics Inc.

NASDAQ:LUCD

$98.28M

CareCloud, Inc.

NASDAQ:CCLD

$97.73M

Cognition Therapeutics, Inc.

NASDAQ:CGTX

$89.03M

Rapid Micro Biosystems, Inc.

NASDAQ:RPID

$79.77M

Sera Prognostics, Inc.

NASDAQ:SERA

$71.42M

DocGo Inc.

NASDAQ:DCGO

$57.25M

SkyAI, Inc.

NASDAQ:STSS

$47.61M

What is the latest JYNT filing?

The latest filing shown is 4 dated Jun 12, 2026.

How many recent filings does JYNT have?

Intrinsic Alpha currently shows 20 recent filings for JYNT.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.